Single Unprovoked Seizures
- PMID: 15043807
- DOI: 10.1007/s11940-004-0016-5
Single Unprovoked Seizures
Abstract
Unprovoked seizures are common, affecting approximately 4% of the population by age 80. Only approximately 30% to 40% of patients with a first seizure will have a second unprovoked seizure (ie, epilepsy). Treatment with antiepileptic drugs (AEDs) should not be initiated unless the diagnosis of a seizure is firm. Decisions regarding treatment of single unprovoked seizures must balance seizure recurrence risk, the potential impact of a recurrent seizure, the likelihood of adverse effects of treatment, and patient preference. Risk factors for seizure recurrence include a history of remote neurologic insult, epileptiform abnormalities on electroencephalogram, focal structural lesion on neuroimaging, and family history of epilepsy. Adult patients with these risk factors have a recurrence risk of 60% to 70% and usually should be treated with an AED to prevent seizure recurrence. Without risk factors, the recurrence risk is 20% to 30%, and treatment depends on individual risk-to-benefit ratios and patient preference. Treatment of a first unprovoked seizure is often not necessary in childhood, especially if the seizure is part of a benign self-limited syndrome, such as benign Rolandic epilepsy of childhood. Treatment with an AED reduces the risk of seizure recurrence after a single unprovoked seizure. This must be balanced against the risk of adverse effects of AEDs. Treatment of the first seizure does not appear to affect the long-term prognosis of epilepsy. The choice of an AED should be guided by the seizure type and likely epilepsy syndrome diagnosis. Monotherapy is preferable. Standard AED options include phenytoin, carbamazepine, valproate, and phenobarbital. The newer AED, including gabapentin, lamotrigine, topiramate, oxcarbazepine, levetiracetam, and zonisamide, have good efficacy, favorable pharmacokinetic profiles, and often fewer adverse effects, supporting their use early in treatment. Not all of the newer AEDs are approved for use as monotherapy. Patients with single seizures should be counseled about seizure first aid and general safety measures, including precautions regarding swimming alone, engaging in high-risk activities, driving, possible seizure precipitation by photic stimuli (in generalized epilepsy), sleep deprivation, and alcohol.
Similar articles
-
Epilepsy.Dis Mon. 2003 Jul;49(7):426-78. doi: 10.1016/s0011-5029(03)00065-8. Dis Mon. 2003. PMID: 12838266 Review.
-
[Antiepileptic drugs in North America].Brain Nerve. 2010 May;62(5):519-26. Brain Nerve. 2010. PMID: 20450099 Review. Japanese.
-
Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review.Cochrane Database Syst Rev. 2019 Jul 18;7(7):CD001911. doi: 10.1002/14651858.CD001911.pub4. Cochrane Database Syst Rev. 2019. PMID: 31318037 Free PMC article.
-
When to start drug treatment for childhood epilepsy: the clinical-epidemiological evidence.Eur J Paediatr Neurol. 2009 Mar;13(2):93-101. doi: 10.1016/j.ejpn.2008.02.010. Epub 2008 Jun 24. Eur J Paediatr Neurol. 2009. PMID: 18567515 Review.
-
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134. doi: 10.3310/hta11370. Health Technol Assess. 2007. PMID: 17903391 Clinical Trial.
Cited by
-
What is the standard approach to assessment of an unprovoked seizure in an adult?: UNITED STATES.Neurol Clin Pract. 2012 Dec;2(4):294-296. doi: 10.1212/CPJ.0b013e318279ad2c. Neurol Clin Pract. 2012. PMID: 23634372 Free PMC article.
-
Using a structured questionnaire improves seizure description by medical students.Int J Med Educ. 2016 Jan 10;7:6-10. doi: 10.5116/ijme.566c.096c. Int J Med Educ. 2016. PMID: 26752118 Free PMC article.
-
SOP: First-ever epileptic seizure in adult patients.Neurol Res Pract. 2019 Feb 28;1:3. doi: 10.1186/s42466-019-0006-4. eCollection 2019. Neurol Res Pract. 2019. PMID: 33324869 Free PMC article.
-
Risk of epilepsy following first unprovoked and acute seizures: Cohort study.Epilepsia. 2025 Apr;66(4):1223-1233. doi: 10.1111/epi.18276. Epub 2025 Feb 3. Epilepsia. 2025. PMID: 39898778 Free PMC article.
-
Suppression of adult neurogenesis increases the acute effects of kainic acid.Exp Neurol. 2015 Feb;264:135-49. doi: 10.1016/j.expneurol.2014.11.009. Epub 2014 Dec 2. Exp Neurol. 2015. PMID: 25476494 Free PMC article.
References
LinkOut - more resources
Full Text Sources